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A striking feature of paralytic poliomyelitis has been its ever changing
epidemiology. In the past, changes seem to have come about in the course of
natural evolution from an endemic to an epidemic pattern, first in one
part of the world, and then in another. At present, the use of effective
vaccines for prevention and for greatly reducing circulation of wild strains
of the virus, have apparently had a real impact on the epidemiological
behavior of the disease and we can perhaps anticipate further shifts, not
only in connection with polioviruses, but with other members of the entero-
virus family, some of which are capable of inducing poliomyelitis-like
illnesses. These latter are assuming increased significance, for as the rates
of true paralytic poliomyelitis decline, poliomyelitis-like illnesses assume
greater relative importance.
In the following discussion, I shall review briefly our current know-
ledge of the epidemiology of poliomyelitis as a model for enteroviruses in
general, with emphasis on newer knowledge which has accumulated as a
result of investigations with oral vaccines, and on some of the factors of im-
portance in planning current vaccination programs. For, although virtual
control of paralytic poliomyelitis has been achieved in large geographical
areas, in others (particularly tropical and sub-tropical ones) the disease
is only now beginning to appear for the first time in epidemic form. In
such countries, wise planning and effective execution of vaccination pro-
grams can forestall the evolution of poliomyelitis as the recurrent scourge
that it has been over the past 75 years in parts of Europe, the United
States, and elsewhere.
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HISTORICAL TRENDS
It is now well recognized that endemic poliomyelitis is world wide in
distribution, and evolution of the disease as an epidemic one within the last
century has followed a characteristic pattern. At first, a few small col-
lections of cases are noted; then a higher than usual endemic rate for a few
years is followed by severe epidemics with high attack rates. The age
group attacked in endemic poliomyelitis and in early epidemics is the
youngest-0-4 years, with 90 per cent of paralytic cases (particularly in
urban areas) being under 5 years of age. Once this pattern of epidemicity
begins, it is apparently irreversible unless preventive vaccination is carried
out. As epidemics recur over a period of years and the average annual
rate reaches 5 to 10 per 100,000 a shift in age incidence occurs, so that
relatively fewer cases are in the youngest children, the peak often occurs
in the 5-14 year group, and an increasing proportion of young adults is
affected. This stage of development naturally poses an alarming situation
since the disease is more severe and the mortality much higher with
increasing age.
In reviewing the world history of poliomyelitis, it is clear that the
above pattern of evolution of the disease has been experienced by many
countries at different times :1- the first were Norway and Sweden, begin-
ning in the latter part of the 19th century; next, epidemics appeared in
the northeastern part of the United States, near the turn of the century;
in Australia and New Zealand in the first quarter of the 20th century;
in the 1930's in Denmark, Austria, Hungary, Switzerland, Italy; not until
the 1940's in Japan, Czechoslovakia, the Union of South Africa, the Nether-
lands, Great Britain and Germany; and in France, Belgium, and most of
the U.S.S.R. after 1950. The years since 1950 have also seen the appearance
of many first epidemics in tropical and sub-tropical countries: Jamaica and
Costa Rica (1954); the Congo (1951); Nicaragua (1958); Singapore
(1958-9); Puerto Rico (1960); and many others, including China (1952)
and Argentina (1956).
Although the exact factors responsible for this pattern of behavior are
still imperfectly understood in spite of more than 60 years of intensive
investigation, a tremendous amount has been learned in the course of many
studies in many parts of the world. During the past 10 years, with the
availability of live, attenuated oral vaccine, a new chapter has been intro-
duced and many earlier observations have been extended and confirmed.
This has been possible because the oral vaccine provides a tool with which
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to study experimental epidemiology in man, a unique opportunity in the
annals of infectious disease research.
MODES OF SPREAD
The evidence clearly indicates that poliomyelitis is a highly contagious
infection spread by human association. It is probably as infectious as
measles, but unlike measles, the main source of infection is not the frank
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FIG. 1. Schematic diagram of the clinical and subclinical forms of poliomyelitis,
correlated with the times at which virus is present in various sites, and the development
of antibodies. (Redrawn from Paul, J. R.')
case (paralytic or nonparalytic), but rather the mild or completely in-
apparent infection. The relative epidemiological importance of clinically
apparent and inapparent cases is indicated by the estimated ratio of cases
to infections' (Fig. 1). Thus in epidemics it has been estimated that only
1-2 per cent of infections are manifested by clinical signs diagnostic of
poliomyelitis. Another 4 to 8 per cent have nonspecific "minor illnesses,"
and the majority, 90-95 per cent of infections, are completely inapparent.
The ratio of infections to cases varies not only in relation to the virulence of
the strain, but according to the age of exposed susceptibles: in young
children there are probably closer to 1,000 infections for each paralytic
case, while in adults this may be only 75 to 1. In any event, no matter which
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form the infection takes, the presence of virus in blood, throat, and feces is
similar, as is the duration of fecal excretion. The development and per-
sistence of antibodies, both neutralizing and complement fixing, is also
identical regardless of whether the infection is a severe paralytic one, or
produces no symptoms or signs whatever.
As with so many contact infections, the exact manner in which polio-
viruses are transmitted from one person to another is imperfectly understood.
Close association, however, such as exists in the family setting, is impor-
tant in giving rise to contact infections.' The oropharynx has been estab-
lished as the portal of entry and infection is readily induced with vaccine
strains by either ingestion or swabbing of the throat. The main portal
of exit is the intestinal tract, and large quantities of virus can be found
in the feces often for many weeks and occasionally for many months.
Excretion from the throat is more difficult to demonstrate: the quantities
present there both in natural and in vaccine induced infections are smaller,
and isolation from saliva has been accomplished only very rarely. Whether
virus travels from the pharynx of one person to the oropharynx of another,
or whether the fecal-oropharyngeal circuit is the major one, has not yet
been firmly established. Epidemiologic evidence indicates that a case is
most infectious during the early phase of infection, sometime before onset
of symptoms or in the first few days of the clinical disease. This coin-
cides with the rather brief period in which virus can be demonstrated in
the throat, a fact which has led some to conclude that the pharyngeal-
oropharyngeal route is the more important, despite the prolonged period of
excretion from the intestinal tract. However, although the evidence is not
conclusive one way or another, there is perhaps more data to support the
view that poliomyelitis is an enteric infection spread primarily by con-
taminated excreta. Thus a poor sanitary environment is conducive to its
dissemination, a feature which does not have a parallel in infections spread
by the respiratory route.' It is evident also that the period of infectiousness
of poliomyelitis parallels closely the period of maximum fecal excretion of
virus, when titers of 104 to 106 tissue culture infective doses (TCD5o) per
gram of stool are usual. Gard has pointed out that the reduced capacity of
the child over two years of age to infect his contacts coincides with the age
at which toilet training normally occurs.8 Furthermore, it has been shown
that in an environment with heavy fecal contamination such as in an
institution for retarded children and young adults, far more spread of
attenuated vaccine virus occurs than among normal individuals in a more
sanitary environment.9"0 In addition, studies with oral vaccine have indi-
s
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cated that spread from vaccinees to contacts occurs even though no demon-
strable virus is present in the throat' and in some instances when throat
infection has been completely bi-passed by feeding virus in capsules.'
Significant multiplication of attenuated strains in the throat, in fact, seems
to be related to vaccine dosage, and only when large amounts (106 to 107
TCD50) are administered has virus been recovered regularly from throat
swabs."8"1' With virulent epidemic strains of much higher infectivity,
however, smaller doses are doubtless required, and spread via pharyngeal
secretions is, therefore, more probable under these circumstances. Taking
all the evidence together, the fecal-oral route seems the more important
one, although direct pharyngeal-oral pharyngeal spread may also play a
role, particularly in epidemic situations.
Extrahuman sources of poliovirusXpread. These have never been regarded
as being of particular importance. Although many animal and arthropod
hosts collected in nature have been tested over the years, only flies and cock-
roaches have yielded polioviruses. " Flies have been trapped and examined
during epidemic and endemic times, and it is clear that various species
(particularly the fecal-feeding ones) can be heavily infected in nature
with various enteroviruses and can contaminate food with poliovirus.
Recent precise quantitative studies by Gudnadottir'8 even indicate that
virus can multiply to some extent in at least one species of fly, and thus
mutation in the fly is conceivable. Despite these varied pieces of informa-
tion, however, the role of flies in dissemination of polioviruses has not
yet been clarified. It has been postulated that they may act as mechanical
vectors particularly in highly endemic tropical areas with poor environ-
mental sanitation. It is obvious however that flies are not essential to
dissemination of polioviruses, since epidemics have occurred in arctic areas
under climactic conditions which preclude the presence of these insects.
The extent to which flies may be contaminated in nature with various
enteroviruses has been documented recently in connection with oral vaccine
trials in Arizonae"" and in Costa Rica. Flies were examined in an effort
to determine whether or not they pick up vaccine strains, and perhaps
can then act as supplementary vaccine disseminators. Figure 2 shows the
isolation of polioviruses from vaccinees and from flies in Costa Rica
during the same pre- and post-vaccinal periods. The patterns are more or
less parallel. The lower part of the chart indicates the variety of other
enteroviruses which were picked up from flies. All of these were also
isolated from children during the same period. Some of the poliovirus
9
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strains from flies had genetic markers like the vaccine strains, while others
were classified as probably "wild." The interpretation of the findings is
difficult, however, and at this stage we are still unable to fit together the
data in a satisfactory manner or to assess the importance of flies in the
over-all epidemiological picture.
INCUBATION PERIOD
In relation to spread of virus the length of the incubation period is of
considerable interest. On the basis of observations on illnesses developing
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in contacts of known cases, and to some extent on the experimental disease
in monkeys, the usual estimate of the incubation period is given as 7 to 14
days with extremes of 5 and 35 days. In general, these intervals refer to
the time between exposure and the appearance of the CNS or second phase
of the disease, i.e. the so-called "major illness." The interval between
exposure and the first phase ("minor illness") has on the other hand long
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FIG. 3. A comparison of the days on which 27 index children excreted type III polio-
virus with the days on which 32 siblings contacts excreted this same virus. The
siblings' infections follow quite closely those of the index children. (From Paul, J. R.:
The spread of attenuated polioviruses among household contacts. In Poliomyelitis.
Papers and Discussions Presented at the Fifth International Poliomyelitis Conference,
Copenhagen, Denmark, July 26-28, 1960. Philadelphia, J. B. Lippincott Co., 1961.)
been recognized as being much shorter.' Just how short the period can be
for the establishment of infection was not appreciated until it was possible
to study the question in persons infected with oral vaccine strains."'' It
soon became apparent that within 24 to 48 hours after vaccination, multipli-
cation occurs, and virus excretion in throat and stools can be observed. This
pattern is now well established, and it would appear that the true incuba-
tion period of the infection is usually 1-3 days, rarely 4-5 days or more.
However, the interval between initiation of infection and appearance of
CNS signs may be as long as several weeks, which accounts for the great
variation in the incubation period of the disease.'
In line with an exceedingly short incubation period is the evidence of
the remarkable speed with which infection can spread from one individual to
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another. This has been demonstrated in a number of investigations includ-
ing a recent one by Paul, et a1.,0 in which it was found that when the
first post-vaccinal specimens were collected 4 days after one child in each
family had ingested trivalent vaccine (Lederle-Cox), both the vaccinees
and their non-vaccinated siblings were excreting polioviruses. As shown in
Figure 3, within 5 days of vaccination of the index child, 63 per cent of
susceptible sibling contacts were excreting type III poliovirus, the most
infectious ofthethree types contained in thevaccine; the subsequent patterns
of excretion by vaccinees and contacts were similar.
Data of this type would seem to make it unnecessary to invoke the
earlier concept of poliomyelitis as being, possibly, a "place infection." Ac-
cording to this latter view, the time relationships in family outbreaks in
which paralytic disease and minor illnesses occurred in various members
all within a matter of a few days, suggested a common source of infection
for the entire group. The newer observations on spread in both institutional
settings9 and natural environments' 20 point rather to an infection which
is introduced by one person but spreads at once to infect susceptible con-
tacts within a few days.
FACTORS AFFECTING DISSEMINATION
Immune status. In general, the circulation of wild polioviruses in a
community is dependent upon the availability of enough susceptible hosts
in which to multiply. Neither susceptibility nor resistance to infection are
simple or absolute, however, as investigations with oral polio-virus vaccines
have emphasized.9''8 This is illustrated in Figure 4 which compares
the duration ofvaccine virus excretion by antibody negative-i.e. susceptible
children, and those who have naturally acquired antibodies and immunity-
resistant children.' It is apparent that far more virus was excreted for
far longer periods by susceptible than by resistant children. As has been
noted by others, among the resistant children there was a roughly inverse
relationship between height ofantibody and virus excretion.1"
Oral vaccine trials have also brought out the complexities of the immune
mechanisms in poliomyelitis: it has become apparent that humoral im-
munity is by no means the whole story, and that there exists a so-called
"local resistance" or tissue immunity which seems to be induced by
actual multiplication of virus in the intestinal tract.98 The nature of this
intestinal resistance is not clearly understood. It may be associated with
some cellular alteration, or possibly a local concentration of antibody in
12
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extracellular fluids. In any event, its presence is of equal if not greater
importance than serum antibodies in providing a barrier to reinfection.
The inactivated vaccine, since its introduction in 1955, has greatly
reduced the incidence of paralytic poliomyelitis in countries in which its
use has been extensive. This has been accomplished by inducing serologic
immunity in vaccinees, which prevents CNS invasion. However the extent
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FIG. 4. Duration of type III poliovirus excretion in vaccinees and siblings infected by
contact. Each line represents one child. The left panel illustrates the situation found in
69 susceptible (S) subjects, and the right panel the situation in 51 resistant (R)
children. (From Paul, J. R., et al.')
to which the inactivated vaccine has suppressed the circulation of wild
polioviruses and the incidence of inapparent intestinal infection is not
well documented. That it has had some effect in this connection seems
definite,' but there is also evidence that wild viruses have continued to
spread and have even caused epidemics in certain well-vaccinated com-
munities.' This is not surprising, for although the vaccine induces antibody
formation, it does not provide a significant barrier to intestinal infection
with either wild or vaccine strains. In contrast, inapparent infection,
either natural or oral vaccine induced, does result in a marked degree of
resistance to intestinal multiplication of virus, although in neither case
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is this resistance absolute. l'-' Reinfection thus can and does occur to
some extent under natural circumstances of exposure, and it can be induced
readily with oral vaccine strains if a large enough dose is administered.
However, when reinfection occurs, virus excretion is limited both in
amount and duration, and reinfected persons are ineffectual virus dissem-
inators.
On the basis of these considerations it is clear that the maximum barriers
to spread of wild polioviruses in any community can be achieved by
inducing both humoral immunity and intestinal resistance in as large a
segment of the susceptible population as possible. Oral attenuated poliovirus
vaccine offers a means of accomplishing this, but it is necessary to vaccinate
a high proportion of the susceptibles in any given area (at least 85 per
cent) in order to achieve adequate community protection against invasion
by wild polioviruses.'
Age. Oral vaccine studies have also yielded important information in
terms of identifying precisely the most likely spreaders of polioviruses.
It is not surprising that age has a profound effect, and that young children,
particularly those under two, besides being the most susceptible to infection,
turn out to be the most successful disseminators of polioviruses. Thus
Gard,8 using the Chat strain of type I vaccine, found that whereas only 4
per cent of orally vaccinated individuals above the age of two years infected
susceptible contacts, more than 40 per cent of children aged six months to
two years did so. Similar results have been reported by Fox, et al." and
others.
These observations bring into sharp focus the importance of adequate
immunization of this youngest age group in any vaccination program. In
any population, pre-school children constitute the bulk of susceptibles
(except perhaps in remote arctic areas) and they are the major spreaders
of virus, acting as the source of infection for susceptible older children and
adults. They have also come into prominence once more as the chief suf-
ferers of paralytic poliomyelitis, in the United States at least. In this
country, school age children have been the ones most adequately immunized
with inactivated vaccine, but efforts to reach young children have been less
successful. Outbreaks of epidemic poliomyelitis in the past five years have,
therefore, been concentrated in the 0-4 age group,' whereas before in-
activated vaccine was introduced, the peak incidence occurred in the 5
to 14 year olds.
Interfering enterotnruses. The important role which other enterovirus
infections have in interfering at times with poliovirus infections has been
14
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demonstrated in oral vaccine studies in several countries. In tropical and
sub-tropical areas such infections are common the year round, particularly
in young children. Thus, in Mexico, Ramos-Alvarez, et al. have shown that
"takes" with poliovirus vaccine strains can be reduced almost 50 per cent
in the presence of high infection rates with other enteroviruses.' The com-
plexities of the interference mechanisms are great; the evidence indicates
that not only the nature of the agent causing the pre-existing infection, but
the time in the course of such an infection, the amount of virus being
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FIG. 5. Virus excretion by vaccinee and siblings in a family free of enterovirus
infection at the time that trivalent vaccine was administered. P = poliovirus. E14 =
ECHO 14 virus. U = untypable agent.
excreted, and the dose of poliovirus constituting the exposure, are all
important determinants. Thus, if oral vaccine is given very early in the
course of another enterovirus infection, it commonly obliterates the latter
and a poliovirus infection is readily established. The same is true if exposure
occurs at the end of another infection. However, if vaccine is fed in
the middle of a vigorous infection in which large amounts of virus are
being excreted, the attenuated poliovirus often fails to gain a foothold:
no excretion and no antibody response occur. These patterns have been
shown by Drozdov and Shirman7 and Hale, et al.' in connection with inter-
ference betweenwild and vaccine strains ofpoliovirus; others, including our-
selves, have made similar observations on interference by various entero-
viruses.'G Figure 5 depicts the course of events in a family in which one child
only was fed trivalent vaccine (Lederle-Cox) twice. In the absence of other
enterovirus infections, the vaccinee became infected with all three types and
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rapid spread to susceptible siblings occurred. In another family, however,
(Figure 6) in which ECHO 12 and an unidentified enterovirus were circu-
lating, no infection and no spread of the vaccine strains was detected. In a
third family (Figure 7) in spite of the presence of infection with ECHO 2,
ECHO 12 and an unidentified agent, the highly infectious poliovirus
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FIG. 6. Failure of vaccine strains to become established in a family already infected
with ECHO 12 and an untypable (U) agent. (From Paul, J. R, et al.w)
type III component of the vaccine was able to get through, infect the vac-
cinee, and spread to susceptible siblings. It is likely that similar dynamics of
infection are involved in the case of natural exposure to wild polioviruses in
the presence of infection with other members of the large and heterogeneous
enterovirus family.
Environmental factors. The important impact of the sanitary environ-
ment on the dissemination of poliovirus infections was elucidated first in
connection with serologic surveys.' Thus in populations living under con-
ditions of poor sanitation and hygiene, poliovirus (as well as other entero-
viruses) have been found to be widely disseminated, with infection and
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antibody responses developing in the first few years of life in close to 100
per cent of children. This results in a highly immune population in which
only the youngest children are susceptible to primary infection; in such a
community epidemics areunknown, andparalytic cases are relatively few and
limited to the infantile age group. In contrast, in populations with high
standards ofliving, exposure, infection, and antibodies appear at increasingly
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FIG. 7. Infection and spread of type III poliovirus vaccine in the presence of other
enterovirus infection. E2 and E12 = ECHO 2 and 12. U = untypable agent. (From
Paul, J. R., et al.')
older ages. This leaves a considerable segment of the population susceptible,
so that when avirulent strain appears, an epidemic may result. The changing
age incidence of paralytic poliomyelitis in economically advanced countries
is well illustrated by the experience of Sweden, where 57 per cent of cases
in the 1953 epidemic occurred in the age group over 20 years; in contrast,
in the Swedish epidemic of 1911, the corresponding figure was 12 per
cent.8"' fi
The close tie between social and sanitary conditions and the appearance
of epidemics in a given population has also been reflected in an inverse
relationship between infant mortality and epidemics. Payne and Paul'
have presented analyses of the history of poliomyelitis in various parts of
17YALE JOURNAL OF BIOLOGY AND MEDICINE
the world in which it has been shown that when the infant mortality falls
to a level of 70-80/100,000, epidemics of poliomyelitis are likely to make
their appearance. This is not a direct relationship but it would seem that
infant mortality is a rough measure of hygienic standards, and the decrease
in rate is a reflection of improved sanitation. With this improvement comes
decreased circulation of enteric agents, including polioviruses, fewer im-
munizing infections in the early months of life, and consequently a build-up
of susceptibles among whom an epidemic may start should a virulent strain
of poliovirus begin spreading. With these facts in mind, a campaign of im-
munization against poliomyelitis becomes a particularly important feature
of health department planning wherever and whenever improved environ-
mental sanitation is causing a rapid fall in infant mortality and a build-up
of susceptibles. In this situation, the problem of vaccination is relatively
simple since adequate levels of immunity can be maintained in the com-
munity if only the youngest children are given oral vaccine-i.e. those
under five, and particularly those under two years of age.
Nature of the infecting strain. Marked differences in the virulence of
naturally occurring strains of polioviruses have been noted. It is apparent
that in most parts of the world, endemic strains of relatively low virulence
circulate widely and often quite silently, particularly among young children.
During this process, mutations are occurring continually, and occasionally
epidemic strains of high virulence arise. Such strains are characterized not
only by their invasiveness and affinity for the CNS, but also by their extra-
ordinary capacity to spread with ease and rapidity to susceptible members of
the population. Wild endemic strains, on the other hand, spread less well
than do epidemic ones, and attenuated vaccine strains have an even more
limited momentum: their dissemination often terminates while there are
still susceptibles avaialble.1' Although less data is available on non-polio-
enteroviruses, it is clear that their circulation is governed by more or
less similar rules. In general the greater the disease producing potential of
a strain, the greater is its spreading potential, whether it be a virulent
poliovirus, or an ECHO 9 such as swept Europe and the United States
in 1957 and 1958.
From the foregoing discussion it is apparent that many factors besides
strain virulence are involved in precipitating first epidemics of polio-
myelitis and in bringing about their recurrence. It is probable that at
different times and different places environmental aspects, host resistance,
and virulence of the virus are of greater or lesser relative importance. But
is
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since epidemic strains are presumed to arise by a process of mutation, the
greater the circulation of polioviruses the more likely is the emergence of
a paralytogenic variant which also has the capacity to spread rapidly. The
conditions in tropical and sub-tropical areas where continual high rates of
infection prevail are optimum for this to occur. Once such a strain has
evolved, it may precipitate an epidemic in its place of origin if enough sus-
ceptibles are available at the time; and it may also be the source of spread to
other areas, if circumstances are right for its transport-i.e., if virus
carriers with inapparent infections are available to introduce it elsewhere.
A possible train of events such as this was proposed by Gear in 1948' to
account for the sudden appearance of first epidemics in Africa in the
1940's. These all took place on the overland route from South Africa to
the Middle Eastern theater of the war. Gear concluded that virulent strains
had been introduced probably by allied troops ("susceptible immigrants")
who had become infected in the Middle East where the strains had
originated. Extensive troop movements resulted then in spread throughout
Africa, and to Mauritius and Malta as well. The new strains were highly
virulent and probably differed antigenically in some subtle way from the
endemic ones which had been circulating previously in these areas. Con-
ceivably, rapid passage in susceptible hosts further enhanced their virulence,
and the result was a series of severe epidemics among the susceptible age
groups in each country in turn.
It is reasonable to suppose that the great movements of military and
civilian populations which accompanied and followed World War II
probably did provide opportunity for introduction of new strains into
various parts of the world. Voroshilova" has mentioned this as a likely
contributing factor in the series of epidemics which began in the U.S.S.R.
in the 1950's. Epidemic poliomyelitis has also appeared for the first time
in many tropical countries in the past 10 years, including Latin America.'
While changing socio-economic patterns, improved sanitation, and falling
infant mortality rates are undoubtedly exerting their influences, the pos-
sibility that new strains have arisen and been disseminated widely as a
result of increased travel also deserves reconsideration, as has recently
been emphasized by Sabin.' In general, once epidemics start in a country,
they continue; if unusually virulent strains are now widely prevalent in
developing countries of the world, the need for immediate and extensive
immunization programs in these areas is greater than ever. The situation
may indeed be considered critical.
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UNSOLVED PROBLEMS
Throughout the above discussion, emphasis has been on poliomyelitis,
the most extensively studied of the enterovirus infections. This approach
would seem to have some reason, since the available evidence indicates that
the epidemiology of this entire family of agents is similar: the same factors
are involved in terms of virus dissemination and the same patterns as far
as susceptibility and immunity.`' The unanswered questions which remain
concerning the epidemiology of poliomyelitis and other diseases caused by
enteroviruses are also similar. It is clear, for example, that in temperate
climates these agents are far more prevalent in the summer season than in
the winter. Why epidemics of enterovirus infection and disease have such
a striking seasonal pattern remains unexplained. The agents are present
the year round, and circulate silently to some extent in the coldest as well
as the warmest season. Still, some as yet mysterious concatenation of
circumstances (probably involving the virus, the host, and the environment)
seems necessary to bring them out in the open, as it were.
Another major question involving the entire enterovirus family con-
cerns the possible effects of mass oral vaccination on the ecology of these
agents. If an entire population has been immunized and offers a relatively
solid block of resistance to the spread of wild polioviruses, what effect, if
any, will this have on the circulation and the disease producing potentials
of other enteroviruses? This question is an open one at present. As has been
pointed out by Dalldorfr it can perhaps be answered best by our colleagues
in the U.S.S.R. who have carried out the most extensive oral vaccine pro-
grams, reaching close to a staggering 100,000,000 persons. Since the various
Soviet Republics represent diverse populations and environmental features
as exemplified by the Baltic republics on the one hand, and the Central
Asian ones at the opposite extreme, it should be possible to obtain answers
in relation to various epidemiological settings. Will reduced circulation
of wild polioviruses occur and persist indefinitely? Will other enteroviruses
be more prevalent, or less so, or unaffected by a reduction in circulating
polioviruses? With these questions in mind, the Yale Poliomyelitis Study
Unit has followed one small New England city of 30,000 population in
which 90 per cent of the child population under 18 years, consisting of
10,000 individuals, was vaccinated in 1961 with the Sabin strains of oral
vaccine. The method of surveillance used was isolation of virus from
sewage, which we have found to be a more sensitive indicator of enterovirus
circulation than rectal swab surveys. Specimens were collected at regular
intervals from various areas of the city, and to our surprise it was found
20
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that before vaccination was begun, in the middle of an extremely cold
January, at least six different enteroviruses (including type III polio-
virus) were circulating silently in this population.' Immediately following
the introduction of type I oral vaccine, however, the sewage was flooded
with this type of poliovirus for six weeks and all else was virtually
obliterated (Table 1). At the end of this time, when types II and III were
administered together to the 10,000 vaccinees, type I was rapidly replaced
by these other types. The latter persisted for some three months when
during July, other enteroviruses, which had apparently been blotted out
for the previous five months, re-appeared and took over for the next
three or four months. The non-polio-enteroviruses isolated were chiefly
Coxsackie B3, B4 and B5 and ECHO 4, 7, and 8. By the end of November,
eight months after vaccination, type III virus re-appeared in the sewage,
and in December, type I did so. Since oral vaccine had not been used
after the community program terminated in the previous March the
presence of polioviruses in December may represent residual circulation
among new susceptibles born or immigrating into the area, or possibly
some circulation of wild strains newly introduced.
The virtual obliteration of the usual enteric viral flora following massive
application of oral vaccine has also been observed by Sabin in Toluca,
Mexico, where trivalent vaccine was given to a population heavily seeded
with enteroviruses.tm In this situation too, the polioviruses became dominant
in the weeks following vaccine administration, but after three months they
were replaced by other agents and poliovirus circulation almost ceased.
These two experiences in two epidemiologically dissimilar environments
support the earlier findings of Zacek, et al.' and Domok, et al." that the
vaccine strains tend to disappear a few months after community-wide ad-
ministration. In both Toluca and Middletown, it was apparent that the
circumstances were suitable for spread of enteroviruses, for a variety of
these circulated steadily after initial apparent suppression by the vaccine
strains.
Knowledge of the ultimate effects of community-wide vaccination in
terms of the behavior of agents which at present seem to have a limited
potential for causing serious or paralytic disease will depend on extensive
laboratory and field investigations carried out in different parts of the
world. In the meantime, it is challenging to speculate on the outcome.
Dalldorf, while emphasizing the unpredictability of ecological changes
generally, has considered the possibility that a decrease in poliovirus
circulation may encourage viruses like the Coxsackie B's to become more
22
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pathogenic. There is both experimental and field evidence of antagonism
between these two groups of agents; in Denmark in particular, high
poliomyelitis years have been low pleurodynia (Coxsackie B) years, and
vice versa. Furthermore, both Coxsackie and certain ECHO viruses are
known to be capable-on occasion-of producing paralytic disease.@"' Thus
it is possible that they may rush into the vacuum left by the departing
polioviruses, and a new breed of enterovirus disease may conceivably
appear.
Reasoning somewhat similarly, Voroshilovae1 has suggested that an
evolutionary gradient of neurovirulence is apparent in the enterovirus
family, with poliovirus type I representing the extreme in severity, followed
by the other poliovirus types, the Coxsackie B and A7 viruses, down through
various ECHO types to those of lowest pathogenicity. There has not yet
been enough time to determine whether the marked reduction in poliovirus
circulation following vaccination will accelerate the development of greater
virulence in other members of the enterovirus family, or whether as Gard
believes' no striking change will occur. In the U.S.S.R., there seems pos-
sibly to have been some increase in paralytic disease due to Coxsackie A7
virus, at least in the Karaganda area ; but elsewhere there has as yet been
no striking upsurge in poliomyelitis-like disease due to other viruses. As
Gard has pointed out, diseases and even epidemics associated with various
ECHO and Coxsackie viruses seem to follow an epidemiologic pattern
similar to that of poliomyelitis, but independent of it. Furthermore, since
there are so many different types of enteroviruses, the disappearance of one
member-viz. poliovirus-would hardly be expected to have a noticeable
effect on the rest. Their very number is probably an indication of infinite
capacity for mutation, and new types with new potentialities may well arise
in the future as in the past.
Definitive answers to these questions we hope-and expect-will become
apparent in the next decades. But in the meantime, perhaps we should be
prepared for surprises, for our knowledge of Nature is very limited.
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